No More Pe Spray
FDA Label NDC 88078-001

7 label sections · Submitted to the FDA by Muhammad Sabih Javed · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Muhammad Sabih Javed for the product No More Pe (NDC 88078-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient                               purpose, use, warnings, directions, other information, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient                               Purpose

Lidocaine
(approx. 10 mg per spray)                 Male Genital Desensitizer

Use

Helps in temporarily prolonging the time until ejaculation.

Warnings

For external use only.
If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.
Avoid contact with the eyes.
Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply 3 or more sprays, not to exceed 10, to head and shaft of penis before intercourse, or use as directed by a doctor.

Wash product off after intercourse.

Other Information

Store at 20–25°C (68–77°F).

Inactive Ingredients

Caprylyl glycol, dipropylene glycol, ethyl alcohol (SDA 40-B), ethylhexylglycerin, hydroxyacetophenone, propylene glycol, purified water.

Product Label

Image Description (Image 1)

Image Description (Image 1)

Image Description (Image 3)

Image Description (Image 3)

Image Description (Image 2)

Image Description (Image 2)

* Please review the disclaimer below.